TCL Archive In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial April 29, 1988
TCL Archive NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer. May 23, 2008
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005